Mundipharma Philippines to extend consumer reach with expanded BETADINE product portfolio

Mundipharma Philippines to extend consumer reach 
with  expanded BETADINE® product portfolio
Congratulations to MundiPharma, a global pharmaceutical firm extending their flagship of BETADINE product portfolio in the Philippines held at Shangri-La The Fort, BGC Taguig Philippines last August 30, 2017.

The celebration was started by parade of colors representing the global presence of Betadine not only in the Philippines, but also in other parts of the world.

As we all know, Betadine is a leading antiseptic brand in the Philippines introducing their new products and soon available in the market. Here they are:

1. Povidone-Iodine (BETADINE®) Dry Powder Spray
- designed to cater for wound care
2. PovidoneIodine (BETADINE®) Throat Spray
- specifically for throat and oral care in innovative delivery formats to meet the needs of consumers seeking antimicrobial remedies at home or on-the-go.
3. BETADINE® Fresh Bliss® Daily Feminine Wash 
-  this product is the expansion of the company’s footprint in the feminine wash category. 
- it has a Gentle Defense Lactic Acid and Anti-itch Avena Oats for gentle daily cleansing and protection.
4. BETADINE® Cold Defense Nasal Spray
- a first-of-its-kind product that offers all-natural, non-drug, non-steroidal formulation that attacks common colds at the source, shortening the duration of illness by up to two days
According to Mr. Gerry Arnedo, Mundipharma Philippines Country Manager, Povidone-iodin Betadine is "The only antiseptic with no record of incidence of resistance "
Mr. Gerry Arnedo, Mundipharma Philippines Country Manager,
“As well as extended distribution, other investment areas include a focus on talent acquisition and training as well as the integration of digital apps and online information to improve access and education of healthcare professionals.

“Given the Philippines’ high rates of mobile connectivity and rising smartphone penetration, ehealth and smartphone applications will be critical to improving healthcare access and knowledge,” he adds. 

All BETADINE products were also displayed at the lobby during the event.
Mundipharma CEO Raman Singh says that the company’s continued investment in the Philippines indicates its confidence in the country’s attractive growth outlook in the consumer healthcare market, backed by growing consumer demand for trusted brands. 

“The Philippines is a high-growth ‘powerhouse’ healthcare market where access, value and product quality are drivers of consumer preference. Our aim is to ensure we are relevant to the increasing expectations of the consumer, bringing more for the millions of people beyond the fringe of traditional healthcare. 

“We are doing this now by introducing a high-quality range of BETADINE® products and treatments supported by a digitally enabled network of partners and medical professionals,” he adds.

Mundipharma Philippines was established in 2005. It has a strong and growing presence, specialising in Pain Management, Consumer Health, Respiratory, Oncology and Oncology Supportive Care. The company employs 160 people. 

To know more about MundiPharma, visit the following:


Post a Comment

My Instagram